Drug Shortage Report for VIRAMUNE XR
| Report ID | 71268 |
| Drug Identification Number | 02367289 |
| Brand name | VIRAMUNE XR |
| Common or Proper name | Viramune |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NEVIRAPINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 30's |
| ATC code | J05AG |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2019-01-02 |
| Estimated end date | Unknown |
| Actual end date | 2019-08-21 |
| Shortage status | Resolved |
| Updated date | 2019-08-22 |
| Company comments | Product has been discontinued effective Aug 21 2019 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-08-22 | English | Compare |
| v6 | 2019-08-21 | French | Compare |
| v5 | 2019-08-21 | English | Compare |
| v4 | 2019-08-21 | French | Compare |
| v3 | 2019-08-21 | English | Compare |
| v2 | 2019-01-04 | French | Compare |
| v1 | 2019-01-04 | English | Compare |
Showing 1 to 7 of 7